510(k) device
NeuroBlate System
Monteris Medical · Neurosurgical Laser With Mr Thermography (ONO, Class II) · First FDA decision Apr 23, 2026, newest Sep 3, 2026Brain tumorsEpilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
8
Naming "NeuroBlate"
MAUDE reports
621
Brand "NeuroBlate", since 2015
PubMed studies
33
Mentioning "NeuroBlate"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NeuroBlate System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- NeuroBlate System510(k)
K262315 · Decided Sep 3, 2026 · 57 days after receipt
Device type: Neurosurgical Laser With Mr Thermography (ONO) · General & Plastic Surgery
- NeuroBlate System510(k)
K260976 · Decided Apr 23, 2026 · 30 days after receipt
Device type: Neurosurgical Laser With Mr Thermography (ONO) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NeuroBlate", any status and sponsor, newest update first.
- Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent GlioblastomasNot yet recruiting
Washington University School of MedicineAcademic, hospital or other
NCT07620548 · 99 participants (planned) · Start Nov 30, 2026 · Primary completion May 31, 2031
Device: NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy · For: Glioblastoma; Glioblastoma, IDH-wildtype; Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Sites: Rochester, Minnesota; St Louis, Missouri
University of FloridaAcademic, hospital or other
NCT06558214 · 20 participants (planned) · Start Dec 10, 2024 · Primary completion Oct 2029
Device: Optune GIO®; NeuroBlate® · For: Recurrent Glioblastoma
Sites: Gainesville, Florida
Washington University School of MedicineAcademic, hospital or other
NCT02311582 · 55 participants · Start Aug 5, 2015 · Primary completion Apr 15, 2024
Device: MRI-guided laser ablation · For: Malignant Glioma
Sites: Gainesville, Florida; St Louis, Missouri
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NeuroBlate", and for the whole product code for context.
This brand
621 reports: 345 malfunction, 252 injury, 23 death
Whole product code ONO
5 reports: 1 malfunction, 4 injury, 0 death
Newest reports for this brand
3009970070-2026-00012 · Received Oct 29, 2026 · Event dated Oct 16, 2026
Device type: Neurosurgical Laser With Mr Thermography (ONO)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NeuroBlate® SystemInjury
3009970070-2026-00010 · Received Oct 22, 2026 · Event dated Oct 8, 2026
Device type: Neurosurgical Laser With Mr Thermography (ONO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma
3009970070-2026-00009 · Received Oct 9, 2026 · Event dated Sep 23, 2026
Device type: Neurosurgical Laser With Mr Thermography (ONO)
Device problem as coded: Break
Patient problem as coded: Unspecified Tissue Injury
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NeuroBlate"[tiab]. The summary above synthesizes these.
- [Stereotactic laser thermocoagulation in epilepsy surgery].
Hoppe C, Witt JA, Helmstaedter C, et al. · Nervenarzt · 2017Review
- Interstitial Thermal Therapy in Mesial Temporal Lobe Epilepsy.
Landazuri P, Cheng JJ, Leuthardt E, et al. · JAMA Neurol · 2025Multicenter Study
- Laser Interstitial Thermal Therapy for Recurrent Glioblastoma: Pooled Analyses of Available Literature.
Munoz-Casabella A, Alvi MA, Rahman M, et al. · World Neurosurg · 2021Systematic Review
- Laser neurosurgery: A systematic analysis of magnetic resonance-guided laser interstitial thermal therapies.
Lagman C, Chung LK, Pelargos PE, et al. · J Clin Neurosci · 2017Comparative Study, Evaluation Study
- Laser interstitial thermotherapy (LiTT) in epilepsy surgery.
Hoppe C, Witt JA, Helmstaedter C, et al. · Seizure · 2017Review
- Minimally Invasive Robotic Laser Corpus Callosotomy: A Proof of Concept.
Singh H, Essayed WI, Deb S, et al. · Cureus · 2017
- Robotic Instruments Inside the MRI Bore: Key Concepts and Evolving Paradigms in Imaging-enhanced Cranial Neurosurgery.
Manjila S, Rosa B, Price K, et al. · World Neurosurg · 2023Review
- Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization.
Rennert RC, Khan U, Bartek J, et al. · Neurosurgery · 2020Research Support, Non-U.S. Gov't
- Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article.
Sloan AE, Ahluwalia MS, Valerio-Pascua J, et al. · J Neurosurg · 2013Clinical Trial, Phase I, Multicenter Study
- A novel use of the NeuroBlate SideFire probe for minimally invasive disconnection of a hypothalamic hamartoma in a child with gelastic seizures.
Wright JM, Staudt MD, Alonso A, et al. · J Neurosurg Pediatr · 2018Research Support, Non-U.S. Gov't
- Adapting Laser Interstitial Thermal Therapy for the Treatment of Naturally Occurring Intracranial Tumors in Dogs.
Mariani CL, Wachsmuth LP, Bramall AN, et al. · Clin Cancer Res · 2025
- A prospective multicenter study of laser ablation for drug resistant epilepsy - One year outcomes.
Landazuri P, Shih J, Leuthardt E, et al. · Epilepsy Res · 2020Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code ONO.
- Visualase Cooled Laser Applicator System (9735559)Medtronic Navigation, Inc. · 510(k) 2026
- Mobile Laser Unit (1001-N2)Clinical Laserthermia Systems, AB · 510(k) 2025
- Visualase V2 MRI-guided Laser Ablation System (9736422)Medtronic Navigation · 510(k) 2025
- Monteris Medical NeuroBlate SystemMonteris Medical · 510(k) 2024
- TRANBERG Thermoguide Therapy SystemClinical Laserthermia Systems, AB · 510(k) 2022
- Visualase MRI-Guided Laser Ablation System (SW 3.4)Medtronic Navigation, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.